Nutranomics Signs Product Supply and Distribution Agreement for Bangladesh
DRAPER, Utah, Nov. 12, 2013 /PRNewswire/ -- Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to announce that the Company has signed a product supply and distribution agreement with Tezarat Trade Corporation of Dhaka, Bangladesh ("Tezarat Trade"). Tezarat Trade is a conglomerate of food, clothing, and health care product manufacturing and distribution companies with its main office in Dhaka, the capital of Bangladesh.
Mr. Sadaruddin Chandu, the owner of Tezarat Trade, and Nutranomics' CEO Dr. Tracy K. Gibbs, have developed a strong professional relationship over the last seven years.
"Mr. Chandu and I have been patiently preparing and waiting for the right time to begin distribution of Nutranomics' products throughout Bangladesh," stated Dr. Gibbs. "The market was just too immature for our products seven years ago, but now we feel that the rapidly growing middle class population in Bangladesh is ready for more organic, quality whole food dietary supplements to improve their health and well-being."
Tezarat Trade is expected to organize local news media and reporters during the first week of December to cover the entry of Nutranomics products into the Bangladesh market. Training of Tezarat Trade sales reps will begin shortly thereafter.
The entry of Nutranomics into the Bangladesh market is part of an aggressive ongoing Asian market and new product expansion currently being undertaken by the Company. Nutranomics currently has established trademark registration in six Asian markets and distribution agreements signed in five countries (Japan, Taiwan, Philippines, Bangladesh, and Korea).
"We anticipate that Tezarat Trade will launch the new product line in Bangladesh during mid-February 2014," concluded Ms. Nichole Clark, Nutranomics' Director of Retail Sales.
Nutranomics is a publicly traded company engaged in research and development of nutritional food products. In 1997, Nutranomics produced and branded its own product line, and began to sell to the retail outlets and to the public. Nutranomics has also produced formulas for hundreds of other companies. Nutranomics' mission is to increase human health and longevity through education and self-awareness. The Company has sales representatives throughout North America and Asia.
For further information regarding Nutranomics, Inc., please contact our investor relations representatives at firstname.lastname@example.org or call toll-free (888) 616-3999.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements." Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include the Company's intent to launch a new product line with Tezarat Trade in Bangladesh. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
SOURCE Nutranomics, Inc.